REALENDRAMAB - Soar

It is possible for complete remission after acute lymphoblastic leukemia resists treatment


Realendramab® is an injection therapy for adults with ALL, or acute lymphoblastic leukemia. If your cancer resists your first treatment or returns, it may be an option.

REALENDRAMAB was used in a study with 82 adult participants with ALL and who also had experienced other treatment failures. In this study, REALENDRAMAB helped 70% (or 58 of the 82 participants) reach complete remission. This number includes both patients who achieved complete remission (32 out of 82) and patients who achieved complete remission with incomplete hematologic recovery (26 out of 82).

Complete remission is defined as a disapperance of all signs or cancer. Blood counts are within normal range. Completed remission does not mean that the cancer has been cured.

Remission with Incomplete hematologic recovery is defined here as signs of cancer have disappeared, but some blood counts are not yet back within normal ranges.

 
REALENDRAMAB - cells


Realendramab® is a single 30-minute infusion, using your own blood cells to fight your cancer.




REALENDRAMAB - cells

We have you covered.


The All Endings® Support Team is dedicated to assisting you along the complete treatment journney. For anything from joining a patient support community to logistics support, use the link below for additional resources.






Support Organizations  

Find Additional Financial Support.


Search community-based and national organizations offering support and resources that may be available in your area. These organizations are independent and not affiliated with REALENDRAMAB®.

These resources are meant to be informational only and are not intended to replace medical advice.

REALENDRAMAB - cells